Kalaris Therapeutics, Inc. (KLRS) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $42.92M | -24.4% |
| 2024 | $56.78M | +26.1% |
| 2023 | $45.02M | -14.4% |
| 2022 | $52.56M | -14.3% |
| 2021 | $61.33M | +245.4% |
| 2020 | $17.76M | -0.2% |
| 2019 | $17.80M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $42.92M | -24.4% |
| 2024 | $56.78M | +26.1% |
| 2023 | $45.02M | -14.4% |
| 2022 | $52.56M | -14.3% |
| 2021 | $61.33M | +245.4% |
| 2020 | $17.76M | -0.2% |
| 2019 | $17.80M | — |